OBJECTIVE: Cross-sectional studies in cancer have revealed the presence of clusters of symptoms (e.g., gastrointestinal, emotional) and of patients (e.g., low or high levels of symptoms), but not much is known about their longitudinal evolution. In addition, their relationships with medical factors (e.g., cancer sites, treatments) and possible consequences (e.g., functioning) have yet to be established. This prospective study assessed the presence of clusters of patients in 828 participants scheduled to undergo surgery for cancer. METHODS: The patients completed the Hospital Anxiety and Depression Scale, the Insomnia Severity Index, the Multidimensional Fatigue Inventory, the EORTC Quality-of-Life-Questionnaire-C30, and a physical symptoms questionnaire at baseline and 2, 6, 10, 14, and 18 months later. RESULTS: Cluster analyses identified between five and eight clusters of patients depending on the time point. The "Low Symptoms" cluster was the most common (24.8 to 35.0% of the sample), whereas one with predominant nausea and vomiting symptoms was among the least common (1.6 to 3.5%). Significant differences were found between cancer sites, treatment regimens, quality of life, and functioning scores. Prostate cancer patients and those treated by surgery only were overrepresented in the "Low" cluster, whereas breast cancer patients were more likely to fall into the "Moderate - Night Sweats" cluster. Clusters with more severe psychological symptoms were associated with lower functioning and quality of life. CONCLUSIONS: This study revealed distinct clusters of patients that varied in number during cancer treatments. Findings also identified some clusters associated with lower quality of life and functioning, which should receive more clinical attention. (PsycINFO Database Record (c) 2014 APA, all rights reserved).
OBJECTIVE: Cross-sectional studies in cancer have revealed the presence of clusters of symptoms (e.g., gastrointestinal, emotional) and of patients (e.g., low or high levels of symptoms), but not much is known about their longitudinal evolution. In addition, their relationships with medical factors (e.g., cancer sites, treatments) and possible consequences (e.g., functioning) have yet to be established. This prospective study assessed the presence of clusters of patients in 828 participants scheduled to undergo surgery for cancer. METHODS: The patients completed the Hospital Anxiety and Depression Scale, the Insomnia Severity Index, the Multidimensional Fatigue Inventory, the EORTC Quality-of-Life-Questionnaire-C30, and a physical symptoms questionnaire at baseline and 2, 6, 10, 14, and 18 months later. RESULTS: Cluster analyses identified between five and eight clusters of patients depending on the time point. The "Low Symptoms" cluster was the most common (24.8 to 35.0% of the sample), whereas one with predominant nausea and vomiting symptoms was among the least common (1.6 to 3.5%). Significant differences were found between cancer sites, treatment regimens, quality of life, and functioning scores. Prostate cancerpatients and those treated by surgery only were overrepresented in the "Low" cluster, whereas breast cancerpatients were more likely to fall into the "Moderate - Night Sweats" cluster. Clusters with more severe psychological symptoms were associated with lower functioning and quality of life. CONCLUSIONS: This study revealed distinct clusters of patients that varied in number during cancer treatments. Findings also identified some clusters associated with lower quality of life and functioning, which should receive more clinical attention. (PsycINFO Database Record (c) 2014 APA, all rights reserved).
Authors: Claudia Trudel-Fitzgerald; Shelley S Tworoger; Elizabeth M Poole; Xuehong Zhang; Edward L Giovannucci; Jeffrey A Meyerhardt; Laura D Kubzansky Journal: Health Psychol Date: 2017-11-20 Impact factor: 4.267
Authors: Laura C Pinheiro; Xianming Tan; Andrew F Olshan; Stephanie B Wheeler; Katherine E Reeder-Hayes; Cleo A Samuel; Bryce B Reeve Journal: Qual Life Res Date: 2017-02-28 Impact factor: 4.147
Authors: Rina S Fox; Sonia Ancoli-Israel; Scott C Roesch; Erin L Merz; Sarah D Mills; Kristen J Wells; Georgia Robins Sadler; Vanessa L Malcarne Journal: Support Care Cancer Date: 2019-06-03 Impact factor: 3.603
Authors: Whitney T Eriksen; Lydia Singerman; Sally A D Romero; Jason Bussell; Frances K Barg; Jun J Mao Journal: J Altern Complement Med Date: 2018 Sep/Oct Impact factor: 2.579
Authors: Danielle B Tometich; Brent J Small; Judith E Carroll; Wanting Zhai; George Luta; Xingtao Zhou; Lindsay C Kobayashi; Tim Ahles; Andrew J Saykin; Jonathan D Clapp; Heather S L Jim; Paul B Jacobsen; Arti Hurria; Deena Graham; Brenna C McDonald; Neelima Denduluri; Martine Extermann; Claudine Isaacs; Asma Dilawari; James Root; Christine Rini; Jeanne S Mandelblatt Journal: J Pain Symptom Manage Date: 2018-11-23 Impact factor: 3.612
Authors: Kay Sundberg; Yvonne Wengström; Karin Blomberg; Maria Hälleberg-Nyman; Catharina Frank; Ann Langius-Eklöf Journal: Support Care Cancer Date: 2017-02-24 Impact factor: 3.603